Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates

Overview of attention for article published in Pharmaceutical Research, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,779 followers.

RT @NPeppas: From Genentech (available on Web): Preclinical PK Considerations for the Development of Antibody Drug Conjugates http://t.co/b…

RT @NPeppas: From Genentech (available on Web): Preclinical PK Considerations for the Development of Antibody Drug Conjugates http://t.co/b…

RT @NPeppas: From Genentech (available on Web): Preclinical PK Considerations for the Development of Antibody Drug Conjugates http://t.co/b…

From Genentech (available on Web): Preclinical PK Considerations for the Development of Antibody Drug Conjugates http://t.co/bYMgvUkVaW